News

Polyrizon Ltd. has initiated preclinical studies for intranasal delivery of benzodiazepines (BZDs) using its proprietary Trap and Target™ platform....

Corvus Pharmaceuticals provided a business update and announced its financial results for the fourth quarter and year ending December...

Merit Medical Systems announced positive six and twelve-month results from the randomized arm of its WAVE trial, studying the...

NeuroNOS, a Beyond Air subsidiary, secured $2 million in private equity funding to advance the preclinical development of a...

Alumis and Kaken Pharmaceutical have partnered to develop and commercialize ESK-001, a selective TYK2 inhibitor, for dermatological conditions in...

Spark Biomedical has completed enrollment in its pivotal Phase II clinical trial for a non-invasive neurostimulation treatment for Neonatal...

Biomea Fusion announced preclinical and clinical data for its investigational menin inhibitor, icovamenib, at the ATTD 2025 Conference. The...

Tenaya Therapeutics announced positive preclinical data for TN-201, its gene therapy candidate for MYBPC3-associated hypertrophic cardiomyopathy (HCM), published in...

Bionano Genomics and Greenwood Genetic Center (GGC) published a study in •Genome Research• demonstrating the use of optical genome...

PROCEPT BioRobotics announced positive three-month results from the WATER III trial, comparing its Aquablation therapy to laser enucleation for...